Short answer · Medically reviewed summary · Last updated: 2026-04-06
The primary ICD-10-CM code for Neuromyelitis Optica (NMO), or Devic Syndrome, is G36.0, while the historical ICD-9-CM code used for clinical classification was 341.0. In the medical community, accurately coding Devic Syndrome / NMO is essential not only for administrative purposes but also for ensuring patients receive appropriate access to specialized therapies. Because Devic Syndrome / NMO is an autoimmune inflammatory disorder that specifically targets the optic nerves and the spinal cord, accurate diagnostic coding helps clinicians track the progression of the disease and facilitates the authorization of essential long-term immunosuppressive or monoclonal antibody treatments. Understanding Clinical Coding for NMO While the ICD-10 code G36.0 specifically identifies "Neuromyelitis optica [Devic]," it is important to note that the diagnostic landscape has evolved.
ICD10 code of Devic Syndrome / NMO and ICD9 code
ICD-10 and ICD-9 codes for Devic Syndrome / NMO, with classification details for clinicians, coders and patients.
The primary ICD-10-CM code for Neuromyelitis Optica (NMO), or Devic Syndrome, is G36.0, while the historical ICD-9-CM code used for clinical classification was 341.0.
In the medical community, accurately coding Devic Syndrome / NMO is essential not only for administrative purposes but also for ensuring patients receive appropriate access to specialized therapies. Because Devic Syndrome / NMO is an autoimmune inflammatory disorder that specifically targets the optic nerves and the spinal cord, accurate diagnostic coding helps clinicians track the progression of the disease and facilitates the authorization of essential long-term immunosuppressive or monoclonal antibody treatments.
Understanding Clinical Coding for NMO
While the ICD-10 code G36.0 specifically identifies "Neuromyelitis optica [Devic]," it is important to note that the diagnostic landscape has evolved. Many patients are now diagnosed under the broader umbrella of Neuromyelitis Optica Spectrum Disorder (NMOSD), which recognizes that the disease can manifest beyond just the optic nerves and spinal cord. When your physician documents your care, they may use specific sub-codes to indicate whether the disease is AQP4-IgG seropositive or seronegative, as this distinction is critical for choosing the right clinical pathway for managing Devic Syndrome / NMO.
Practical Implications for Patients
For those navigating the complexities of Devic Syndrome / NMO, these codes serve as a bridge to insurance coverage and specialized care. If you find discrepancies in your medical records, it is helpful to discuss these with your neurologist to ensure your documentation reflects the current criteria. We understand that dealing with administrative requirements while managing a rare condition can be overwhelming; however, ensuring your records are updated to reflect the latest diagnostic terminology can provide better continuity of care as you work with your healthcare team to minimize relapses and preserve neurological function.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your neurologist or other qualified health provider with any questions regarding your medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: Portal for rare diseases and orphan drugs
- The Sumaira Foundation for NMO
- Online Mendelian Inheritance in Man (OMIM)
